↑Choi-Miura NH, Tobe T, Sumiya J, Nakano Y, Sano Y, Mazda T, Tomita M (Dec 1996). "Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator". J Biochem. 119 (6): 1157–65. doi:10.1093/oxfordjournals.jbchem.a021362. PMID8827452.
↑Romisch J (Nov 2002). "Factor VII activating protease (FSAP): a novel protease in hemostasis". Biol Chem. 383 (7–8): 1119–24. doi:10.1515/BC.2002.121. PMID12437095.
Gupta S, Batchu RB, Datta K (1992). "Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface". Eur. J. Cell Biol. 56 (1): 58–67. PMID1724753.
Sumiya J, Asakawa S, Tobe T, et al. (1998). "Isolation and characterization of the plasma hyaluronan-binding protein (PHBP) gene (HABP2)". J. Biochem. 122 (5): 983–90. doi:10.1093/oxfordjournals.jbchem.a021861. PMID9443814.
Choi-Miura NH, Yoda M, Saito K, et al. (2001). "Identification of the substrates for plasma hyaluronan binding protein". Biol. Pharm. Bull. 24 (2): 140–3. doi:10.1248/bpb.24.140. PMID11217080.
Choi-Miura NH, Takahashi K, Yoda M, et al. (2001). "Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein". Biol. Pharm. Bull. 24 (5): 448–52. doi:10.1248/bpb.24.448. PMID11379758.
Roemisch J, Feussner A, Nerlich C, et al. (2003). "The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP)". Blood Coagul. Fibrinolysis. 13 (5): 433–41. doi:10.1097/00001721-200207000-00008. PMID12138371.
Wang KK, Liu N, Radulovich N, et al. (2002). "Novel candidate tumor marker genes for lung adenocarcinoma". Oncogene. 21 (49): 7598–604. doi:10.1038/sj.onc.1205953. PMID12386823.
Etscheid M, Beer N, Fink E, et al. (2003). "The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin". Biol. Chem. 383 (10): 1633–43. doi:10.1515/BC.2002.184. PMID12452440.
Willeit J, Kiechl S, Weimer T, et al. (2003). "Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosis". Circulation. 107 (5): 667–70. doi:10.1161/01.CIR.0000055189.18831.B1. PMID12578864.
Anderson NL, Polanski M, Pieper R, et al. (2004). "The human plasma proteome: a nonredundant list developed by combination of four separate sources". Mol. Cell. Proteomics. 3 (4): 311–26. doi:10.1074/mcp.M300127-MCP200. PMID14718574.
Deloukas P, Earthrowl ME, Grafham DV, et al. (2004). "The DNA sequence and comparative analysis of human chromosome 10". Nature. 429 (6990): 375–81. doi:10.1038/nature02462. PMID15164054.
Hoppe B, Tolou F, Radtke H, et al. (2005). "Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism". Blood. 105 (4): 1549–51. doi:10.1182/blood-2004-08-3328. PMID15486068.
van Minkelen R, de Visser MC, Vos HL, et al. (2005). "The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis". Blood. 105 (12): 4898, author reply 4899. doi:10.1182/blood-2005-02-0576. PMID15933067.
Etscheid M, Beer N, Dodt J (2006). "The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration". Cell. Signal. 17 (12): 1486–94. doi:10.1016/j.cellsig.2005.03.007. PMID16153533.